about
Metalloid compounds as drugsThe elements of life and medicinesA potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologueCharacterization of the Dynamic Equilibrium between Closed and Open Forms of the Benzoxaborole Pharmacophore.Repurposing Suzuki Coupling Reagents as a Directed Fragment Library Targeting Serine Hydrolases and Related EnzymesClick Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors.Synthesis of 1,2,3-triazol-1-yl-methaneboronic acids via click chemistry: an easy access to a new potential scaffold for protease inhibitors.Current epidemiology and growing resistance of gram-negative pathogens.1,2-Azaborine: The Boron-Nitrogen Derivative of ortho-BenzyneAntimalarial Benzoxaboroles Target Plasmodium falciparum Leucyl-tRNA Synthetase.A Divalent Protecting Group for Benzoxaboroles.Heats of Formation for the Boronic Acids R-B(OH)2 and Boroxines R3B3O3 (R=H, Li, HBe, H2B, H3C, H2N, HO, F, and Cl) Calculated at the G2, G3, and G4 Levels of Theory.Recent advances in azaborine chemistry.Boron and nucleic acid chemistries: merging the best of both worlds.Molecular recognition with boronic acids-applications in chemical biology.One ring to rule them all: Current trends in combating bacterial resistance to the β-lactamsSugar-boronate ester scaffold tethered pyridyl-imine palladium(II) complexes: synthesis and their in vitro anticancer evaluation.Cytotoxicity of the Urokinase-Plasminogen Activator Inhibitor Carbamimidothioic Acid (4-Boronophenyl) Methyl Ester Hydrobromide (BC-11) on Triple-Negative MDA-MB231 Breast Cancer Cells.Molecular characterization of the boron adducts of the proteasome inhibitor bortezomib with epigallocatechin-3-gallate and related polyphenols.An efficient 2D 11B-11B solid-state NMR spectroscopy strategy for monitoring covalent self-assembly of boronic acid-derived compounds: the transformation and unique architecture of bortezomib molecules in the solid state.Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles.Ring Structure and Aromatic Substituent Effects on the pK a of the Benzoxaborole Pharmacophore.Tavaborole, a novel boron-containing small molecule for the topical treatment of onychomycosis, is noncarcinogenic in 2-year carcinogenicity studies.Academic-Industrial Collaboration: Toward the Consilience of Two Solitudes.Synthesis and biological activity of arylspiroborate salts derived from caffeic Acid phenethyl ester.Potency and spectrum of activity of AN3365, a novel boron-containing protein synthesis inhibitor, tested against clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli.Organocatalytic, enantioselective synthesis of benzoxaboroles via Wittig/oxa-Michael reaction Cascade of α-formyl boronic acids.Adsorption of benzoxaboroles on hydroxyapatite phases.Catalytic enantioselective one-pot aminoborylation of aldehydes: a strategy for construction of nonracemic α-amino boronates.Facile synthesis of borofragments and their evaluation in activity-based protein profiling.Influence of fluorine substituents on the NMR properties of phenylboronic acids.Monitoring of reversible boronic acid-diol interactions by fluorine NMR spectroscopy in aqueous media.Multicomponent mapping of boron chemotypes furnishes selective enzyme inhibitors.Electronic structure of BN-aromatics: Choice of reliable computational tools.Probing a General Rule towards Thermodynamic Stabilities of Mono BN-doped Lower Polyenes.Oxidative Difunctionalization of Alkenyl MIDA Boronates: A Versatile Platform for Halogenated and Trifluoromethylated α-Boryl Ketones.Amphoteric Borylketenimines: Versatile Intermediates in the Synthesis of Borylated Heterocycles.One-pot synthesis of benzoxaborole derivatives from the palladium-catalyzed cross-coupling reaction of alkoxydiboron with unprotected o-bromobenzylalcohols.Folic acid-conjugated 4-amino-phenylboronate, a boron-containing compound designed for boron neutron capture therapy, is an unexpected agonist for human neutrophils and platelets.Hot peppers for a healthier future: boron-containing capsaicinoids.
P2860
Q26822682-6D762579-7EA9-4274-981D-94E01808BD77Q28649323-9D7D6E2A-7899-40A0-9ABB-CCBC949C3CD6Q30045921-E2011F75-8016-4052-9A31-2C953D59F378Q31150113-A70F9CA3-5CD8-45AE-B1AB-96299FA2E520Q33832789-D319215A-F1F4-4885-B4FB-2D8ED6DE32BDQ35671797-00DFCBC5-8C63-4DE2-9CE4-1C1BEE93177DQ35924628-6003EF5B-4C6D-40D6-989D-9D435B8F51C7Q36025192-D2214FDA-56EB-4E92-8FEF-0150D2F6429DQ36045349-EACFD8D9-9968-44F4-818A-F8536DDBD753Q37120074-F9193F43-742B-423D-A7C8-8DB72559FFF1Q37542650-DE69302F-25BA-4CC6-9F5A-79B75174AC3EQ37641732-9066FBEF-DFB6-49C2-9145-A6AEFD0CF755Q38014340-D8488C94-A9A9-4ADB-9248-3FDD3887E4F9Q38094018-D861F689-703A-472B-ABC6-E7C3573EDF4BQ38178990-084356E1-42AA-40E1-91A4-27787BEAA68BQ38712471-079234D4-CEDA-4474-8993-C4886EA61A0FQ38833511-F3E4EEE1-A365-4248-BB44-66065DB78C14Q38869026-F2DF874C-07EB-4CF7-9955-BB8F5F581EC9Q38911003-48D0221F-6A0E-4FF7-84CA-977BA8C8F9F6Q39140225-C6B35F2F-8077-419F-8485-D28337D91AB8Q39430096-FEBF526D-9D45-4A55-A253-FC204E3C89D6Q39736715-6E8FF62D-681C-4655-80B0-DEB91B1FE6CEQ41747362-295A6757-F576-4B94-A156-7D413ECDBF68Q41923139-A75031D6-C22E-4AD1-86A7-6D0102A20190Q41966221-32EBCC67-9FDA-4EDC-A5C9-8F244BD2CBD9Q41974370-F9AB5E71-D1CD-45A6-9CB9-6FD300F3C9B0Q42292802-1C8740E6-9C98-4A86-AE26-61BE1E37CE34Q42388829-26F2F33D-81DC-4794-B1B7-D23CA7B615FBQ42566431-7AFDA25D-4971-485A-9926-B728048F5521Q43148837-39ACBF22-DE88-413A-B93D-A61EF260D036Q45973906-95FC41F2-7F3F-4974-B6C7-CE3D8C6CFE7FQ46693011-ACE5F6FE-E696-4A5E-B870-97958C562112Q47104782-3892B7EB-254B-4E6A-9863-27E90D99F0DDQ48049981-D617D9F3-BD07-445E-9B5A-E978DE764163Q48050492-C14A21B5-BAC6-453A-9BB3-6080419EEE09Q48148739-6D2B74E0-7D56-4D9C-9B13-4BF268102A12Q48184277-EFF07621-BE16-4E37-A4E1-8D4253E581D2Q50208777-3B6A2A9C-C88B-4C09-946C-E735A5D330BAQ50475877-0B7A3DD4-28A3-4CC6-B684-B65675EFB67CQ51041854-182DE7FF-2EEC-40F9-9A45-BA1341C1CA99
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Boron-containing inhibitors of synthetases.
@en
Boron-containing inhibitors of synthetases.
@nl
type
label
Boron-containing inhibitors of synthetases.
@en
Boron-containing inhibitors of synthetases.
@nl
prefLabel
Boron-containing inhibitors of synthetases.
@en
Boron-containing inhibitors of synthetases.
@nl
P2093
P2860
P356
P1476
Boron-containing inhibitors of synthetases.
@en
P2093
John W Tomsho
Stephen J Baker
Stephen J Benkovic
P2860
P304
P356
10.1039/C0CS00131G
P577
2011-02-07T00:00:00Z